April 17–22, 2026 · San Diego · 2418 items
Over 22,000 attendees and more than 7,400 abstracts, including a record 265 clinical trial abstracts. This section collects on-site analysis across fifteen signal directions, plus late-breaking, clinical-trial and new-drug abstracts.
Douglas R. Lowy and John T. Schiller (NCI) received the 2026 Pezcoller-AACR International Award for co-developing the HPV vaccine. HPV causes about 690,000 cancer diagnoses a year; the WHO recently recommended single-dose vaccination.
Incredibly clean safety profile for Zoldonrasib (KRAS G12D)!
New research on #HIV + #cancer presented by
Stellar session about the latest advances in bladder cancer
At #AACR26, Timothy Yap, MBBS, PhD (
Zoldonrasib Deemed Safe, Effective in KRAS G12D-mutant #LungCancer
Congratulations to the AACR Trailblazer Cancer Research Grants recipients, supported by
Excited to see our manuscript published in
11 things I learned at #AACR26 Industry Partnering event – number 7 may well surprise you:
The chairman aka TAY TAY presenting at the plenary clinic trial session at #AACR26!
If you’ll be at #AACR26, come by Room 14 (Mezzanine Level) and say hi!